期刊
ENDOCRINOLOGY AND METABOLISM
卷 36, 期 4, 页码 865-874出版社
KOREAN ENDOCRINE SOC
DOI: 10.3803/EnM.2021.1108
关键词
Aldosterone; Sarcopenia; Muscle development; Receptors; mineralocorticoid; Oxidative stress
资金
- National Research Foundation of Korea (NRF) - South Korean government (MSIT) [2019R1A2C2006527, 2021R1C1-C2006842]
- National Research Foundation of Korea [2019R1A2C2006527] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The study showed that aldosterone treatment inhibited muscle differentiation in mouse C2C12 myoblasts in a dose-dependent manner and increased intracellular reactive oxygen species levels. The interaction between mineralocorticoid receptor and aldosterone in myoblasts was confirmed, and blocking this interaction reversed the effects of aldosterone on muscle cells. These findings suggest that aldosterone plays a direct role in muscular deterioration and antioxidant or mineralocorticoid receptor antagonists could be potential therapeutic options for sarcopenia reduction.
Background: Despite clinical evidence indicating poor muscle health in subjects with primary aldosteronism (PA), it is still unclear whether the role of aldosterone in muscle metabolism is direct or mediated indirectly via factors, such as electrolyte imbalance or impaired glucose uptake. As one approach to clarify this issue, we investigated the effect of aldosterone on in vitro myogenesis and the potential mechanism explaining it. Methods: Myogenesis was induced in mouse C2C12 myoblasts with 2% horse serum. Immunofluorescence, quantitative reverse transcription polymerase chain reaction, Western blot, viability, and migration analyses were performed for experimental research. Results: Recombinant aldosterone treatment suppressed muscle differentiation from mouse C2C12 myoblasts in a dose-dependent manner, and consistently reduced the expression of myogenic differentiation markers. Furthermore, aldosterone significantly increased intracellular reactive oxygen species (ROS) levels in myotubes, and treatment with N-acetyl cysteine, a potent biological thiol antioxidant, reversed the decrease of myotube area, myotube area per myotube, nucleus number per myotube, and fusion index due to aldosterone through decreasing oxidative stress. A binding enzyme-linked immunosorbent assay confirmed that mineralocorticoid receptor (MR) interacted with aldosterone in C2C12 myoblasts, while eplerenone, an MR inhibitor, blocked aldosterone-stimulated intracellular ROS generation during myogenesis and markedly attenuated the suppression of in vitro myogenesis by aldosterone. Conclusion: These findings support the hypothesis that hypersecretion of aldosterone, like PA, directly contributes to muscular deterioration and suggest that antioxidants and/or MR antagonists could be effective therapeutic options to reduce the risk of sarcopenia in these patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据